TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome EP News Bureau Oct 14, 2020 Taysha anticipates that it will submit an Investigational New Drug (IND) application for TSHA-102 to the FDA in 2021
